Press Releases

Year

Feb 2006

LIFELINE THERAPEUTICS, INC. ANNOUNCES Q2 FY 2006 FINANCIAL AND OPERATING RESULTS

LIFELINE THERAPEUTICS, INC. ANNOUNCES Q2 FY 2006 FINANCIAL AND OPERATING RESULTS DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, today announced $1.7 million of revenues and a loss of $(571,044), or $(.03) per share, for its second

PDF Version

Feb 2006

DR. SEAN O'CONNELL JOINS LIFELINE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD

DR. SEAN O'CONNELL JOINS LIFELINE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, announced today that Sean M. O'Connell, Ph.D. has joined its Scientific Advisory Board. Dr.

PDF Version

Feb 2006

LIFELINE THERAPEUTICS, INC. SCHEDULES SECOND QUARTER EARNINGS CONFERENCE CALL AND WEBCAST

LIFELINE THERAPEUTICS, INC. SCHEDULES SECOND QUARTER EARNINGS CONFERENCE CALL AND WEBCAST DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, will hold a conference call on Monday, February 13, 2006 at 8:00 a.m. MST (10:00 a.m.

PDF Version

Feb 2006

DR. LARRY GOLD JOINS LIFELINE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD

DR. LARRY GOLD JOINS LIFELINE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, announced today that Larry Gold, Ph.D., has joined its Scientific Advisory Board. Dr.

PDF Version

Feb 2006

LIFELINE THERAPEUTICS, INC. FILES AMENDMENT NO. 1 TO SB-2

LIFELINE THERAPEUTICS, INC. FILES AMENDMENT NO. 1 TO SB-2 DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, today announced that it has filed Form SB-2 Amendment 1 with the Securities and Exchange Commission. The document is a

PDF Version

Feb 2006

LIFELINE THERAPEUTICS, INC. ENGAGES TAGLICH BROTHERS, INC.

LIFELINE THERAPEUTICS, INC. ENGAGES TAGLICH BROTHERS, INC. DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, today announced that it has engaged Taglich Brothers, Inc. to create and disseminate comprehensive quarterly research reports.

PDF Version

Jan 2006

HUMAN STUDY SHOWS PROTANDIM® PROVIDES A FUNDAMENTALLY NEW APPROACH TO ANTIOXIDANT THERAPY

New scientific data demonstrate Protandim® improves the body's natural ability to reduce oxidative stress by increasing activity of antioxidant enzymes

PDF Version

Jan 2006

LIFELINE THERAPEUTICS, INC. NAMES GERALD J. HOUSTON CHIEF FINANCIAL OFFICER

LIFELINE THERAPEUTICS, INC. NAMES GERALD J. HOUSTON CHIEF FINANCIAL OFFICER DENVER, Colo. (Jan. 4, 2006) — Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, today named Gerald J. ("Jerry") Houston as its chief financial officer (CFO), effective immediately. Former CFO William B.

PDF Version

Pagination

First page
Previous page
…
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Current page 47